首页> 美国卫生研究院文献>EMBO Molecular Medicine >MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways
【2h】

MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways

机译:MicroRNA-146通过抑制促炎途径抑制内皮激活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Activation of inflammatory pathways in the endothelium contributes to vascular diseases, including sepsis and atherosclerosis. We demonstrate that miR-146a and miR-146b are induced in endothelial cells upon exposure to pro-inflammatory cytokines. Despite the rapid transcriptional induction of the miR-146a/b loci, which is in part mediated by EGR-3, miR-146a/b induction is delayed and sustained compared to the expression of leukocyte adhesion molecules, and in fact coincides with the down-regulation of inflammatory gene expression. We demonstrate that miR-146 negatively regulates inflammation. Over-expression of miR-146a blunts endothelial activation, while knock-down of miR-146a/b in vitro or deletion of miR-146a in mice has the opposite effect. MiR-146 represses the pro-inflammatory NF-κB pathway as well as the MAP kinase pathway and downstream EGR transcription factors. Finally, we demonstrate that HuR, an RNA binding protein that promotes endothelial activation by suppressing expression of endothelial nitric oxide synthase (eNOS), is a novel miR-146 target. Thus, we uncover an important negative feedback regulatory loop that controls pro-inflammatory signalling in endothelial cells that may impact vascular inflammatory diseases.
机译:内皮中炎性途径的激活导致血管疾病,包括败血症和动脉粥样硬化。我们证明了miR-146a和miR-146b在暴露于促炎性细胞因子后在内皮细胞中被诱导。尽管miR-146a / b基因座的快速转录诱导是部分由EGR-3介导的,但与白细胞粘附分子的表达相比,miR-146a / b的诱导被延迟和持续,实际上与下降有关。 -调节炎症基因的表达。我们证明,miR-146负调节炎症。 miR-146a的过表达会抑制内皮细胞的激活,而在体外敲低miR-146a / b或在小鼠中删除miR-146a具有相反的作用。 MiR-146抑制促炎性NF-κB途径以及MAP激酶途径和下游EGR转录因子。最后,我们证明HuR是一种通过抑制内皮一氧化氮合酶(eNOS)的表达来促进内皮激活的RNA结合蛋白,是一种新型的miR-146靶标。因此,我们发现了一个重要的负反馈调节回路,该回路控制着可能影响血管炎性疾病的内皮细胞中促炎性信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号